1. Home
  2. IMNN vs CCTG Comparison

IMNN vs CCTG Comparison

Compare IMNN & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • CCTG
  • Stock Information
  • Founded
  • IMNN 1982
  • CCTG 1993
  • Country
  • IMNN United States
  • CCTG Hong Kong
  • Employees
  • IMNN N/A
  • CCTG N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • CCTG
  • Sector
  • IMNN Health Care
  • CCTG
  • Exchange
  • IMNN Nasdaq
  • CCTG Nasdaq
  • Market Cap
  • IMNN 12.9M
  • CCTG 12.7M
  • IPO Year
  • IMNN 1985
  • CCTG 2024
  • Fundamental
  • Price
  • IMNN $5.33
  • CCTG $2.34
  • Analyst Decision
  • IMNN Buy
  • CCTG
  • Analyst Count
  • IMNN 2
  • CCTG 0
  • Target Price
  • IMNN $182.61
  • CCTG N/A
  • AVG Volume (30 Days)
  • IMNN 153.1K
  • CCTG 790.1K
  • Earning Date
  • IMNN 11-06-2025
  • CCTG 09-26-2025
  • Dividend Yield
  • IMNN N/A
  • CCTG N/A
  • EPS Growth
  • IMNN N/A
  • CCTG N/A
  • EPS
  • IMNN N/A
  • CCTG N/A
  • Revenue
  • IMNN N/A
  • CCTG $17,631,489.00
  • Revenue This Year
  • IMNN N/A
  • CCTG N/A
  • Revenue Next Year
  • IMNN N/A
  • CCTG N/A
  • P/E Ratio
  • IMNN N/A
  • CCTG N/A
  • Revenue Growth
  • IMNN N/A
  • CCTG 19.55
  • 52 Week Low
  • IMNN $4.70
  • CCTG $0.99
  • 52 Week High
  • IMNN $41.22
  • CCTG $3.17
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 47.96
  • CCTG 77.01
  • Support Level
  • IMNN $5.04
  • CCTG $1.04
  • Resistance Level
  • IMNN $5.55
  • CCTG $1.40
  • Average True Range (ATR)
  • IMNN 0.29
  • CCTG 0.27
  • MACD
  • IMNN 0.04
  • CCTG 0.11
  • Stochastic Oscillator
  • IMNN 70.94
  • CCTG 96.79

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

Share on Social Networks: